SCHEMBL2143972

SCHEMBL2143972

C[C@@H](c1ccccc1)N(C)C(=O)c1ccc2cccnc2c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.57
▸ EGLN1 Q9GZT9 7/20 0.52
▸ HSP90AA1 P07900 3/20 0.47
▸ P4HB P07237 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ HIF1A Q16665 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ SLC2A1 P11166 1/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ TACR1 P25103 2/20 0.45
▸ RCE1 Q9Y256 2/20 0.44
▸ PAX8 Q06710 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2143980 1.00 ALDH1A1 (0.57) ALDH1A1EGLN1HSP90AA1P4HBTP53
SCHEMBL12522399 1.00 ALDH1A1 (0.57) ALDH1A1EGLN1HSP90AA1P4HBTP53
SCHEMBL2143852 0.80 ALDH1A1 (0.62) ALDH1A1EGLN1KMT2AL3MBTL1
SCHEMBL16735685 0.77 EGLN1 (0.45) ALDH1A1EGLN1TP53RAB9ATACR1
SCHEMBL7687801 0.77 ALDH1A1 (0.66) ALDH1A1EGLN1L3MBTL1
SCHEMBL2143783 0.77 EGLN1 (0.60) ALDH1A1EGLN1HSP90AA1TP53HPGD
SCHEMBL2143913 0.77 EGLN1 (0.63) ALDH1A1EGLN1HSP90AA1P4HBHPGD
SCHEMBL2143917 0.77 EGLN1 (0.63) ALDH1A1EGLN1HSP90AA1P4HBHPGD
SCHEMBL2143826 0.76 ALDH1A1 (0.60) ALDH1A1EGLN1HPGDHSD17B10
Hydrochloric Acid SCHEMBL7692786 0.76 ALDH1A1 (0.64) ALDH1A1EGLN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 — — EP claimed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US claimed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US claimed
EP-2519505-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF Polichem SA (LU) 2012-11-07 — — EP claimed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 — — EP claimed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 — — WO claimed
EP-2519505-B1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2015-05-27 — — EP disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-8729098-B2 Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM SA (LU) 2014-05-20 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM SA (LU) 2012-12-06 — — US disclosed
EP-2519505-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF Polichem SA (LU) 2012-11-07 — — EP disclosed
EP-2345643-A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof POLICHEM S.A. (LU) 2011-07-20 — — EP disclosed
WO-2011080264-A1 NEW TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF POLICHEM S.A. (LU) 2011-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309751-A1 TERTIARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES AND USES THEREOF TUBA8, SUCLG1, TUBB8 ALDH1A1 931/4885EGLN1 777/4885HSP90AA1 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback